Description Usage Format Details Note Source References Examples
The data are from the Skin Cancer Prevention Study, a randomized, double-blind, placebo-controlled clinical trial of beta-carotene to prevent non-melanoma skin cancer in high risk subjects.
1 |
A data frame with 7081 observations on the following 9 variables.
ida factor with 1683 levels
centera factor with levels C1, C2,
C3, C4
agea numeric vector
skina factor with levels otherwise and
burns
gendera factor with levels F and M
nExposurea numeric vector; number of previous skin cancers
nCancersa numeric vector; number of new skin cancers per year
treatmenta factor with levels placebo and
B-carotene
yeara numeric vector; year of follow-up
A total of 1805 subjects were randomized to either placebo or 50mg of beta-carotene per day for 5 years. Subjects were examined once a year and biopsied if a cancer was suspected to determine the number of new skin cancers occurring since the last exam. The outcome variable is a count of the number of new skin cancers per year. The outcome variable Y is a count of the of the number of new skin cancers per year. The categorical variable Treatment is coded 1=beta-carotene, 0=placebo. The variable Year denotes the year of follow-up. The categorical variable Gender is coded 1=male, 0=female. The categorical variable Skin denotes skin type and is coded 1=burns, 0=otherwise. The variable Exposure is a count of the number of previous skin cancers. The variable Age is the age (in years) of each subject at randomization. Complete data are available on 1683 subjects comprising a total of 7081 measurements.
Original variable names have been adapted to R conventions. The
center ID was prefixed with the letter āCā in the center
variable, compared to the source.
http://biosun1.harvard.edu/~fitzmaur/ala
Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, Elias PM, Lowe N, Nierenberg DW, Bayrd G, Vance JC, Freeman DH, Clendenning WE, Kwan T, the Skin Cancer Prevention Study Group (1990) A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. New England Journal of Medicine 323:789-795
1 2 |
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.